Vår teknik har använts i flera studier under de senaste åren. Vårt engagemang i dessa studier syftar till att visa upp de olika tillämpningar som vår teknik kan användas för. Varje pilotstudie bidrar till att förbättra vår förståelse för kapaciteten och flexibiliteten hos vår teknik, samtidigt som vi utforskar nya möjligheter och tillämpningar inom området.
International pilot study in collaboration with a research group at University Hospitals Coventry and Warwickshire in the United Kingdom
Purpose:
The study focused on detecting immunocomplex and complement deposition in renal biopsies using Lumito’s technology.
Results:
The results will be presented in June at Liverpool Congress Pathology 2023 through a poster presentation.
Collaboration with a research group at Umeå University in Sweden
Purpose:
The study explored the capacity of Lumito’s technology when quantifying signals compared to traditional DAB staining.
Results:
The study proved that Lumito’s technology offers more precise measurement results compared to traditional DAB staining, which saturates quickly and decreases the possibility of correct quantification. The research group in Umeå wrote an article about the study published in Cancer Immunology Research. See a presentation of the results here.
Telefon: +46(0)10-204 00 15
Mail: info@lumito.se
Lumito AB (publ)
Scheelevägen 19, SE-223 63 Lund, Sweden